{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T23:51:56Z","timestamp":1793922716804,"version":"4.8.0"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100015694","name":"Fondazione Cassa di Risparmio di Firenze","doi-asserted-by":"publisher","award":["20451"],"award-info":[{"award-number":["20451"]}],"id":[{"id":"10.13039\/501100015694","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007076","name":"Airc Italian Foundation for Cancer Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007076","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007366","name":"Italian Multiple Sclerosis Association","doi-asserted-by":"publisher","award":["2022\/R-Single\/023"],"award-info":[{"award-number":["2022\/R-Single\/023"]}],"id":[{"id":"10.13039\/100007366","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Neurology"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.expneurol.2024.115095","type":"journal-article","created":{"date-parts":[[2024,12,12]],"date-time":"2024-12-12T17:06:10Z","timestamp":1734023170000},"page":"115095","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Microglial suppression by myeloperoxidase inhibitor does not delay neurodegeneration in a mouse model of progressive multiple sclerosis"],"prefix":"10.1016","volume":"385","author":[{"given":"Alessandra","family":"Pistolesi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Ranieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maura","family":"Calvani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniele","family":"Guasti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Chiarugi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Buonvicino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.expneurol.2024.115095_bb0005","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s40478-018-0510-8","article-title":"Brain region-specific enhancement of remyelination and prevention of demyelination by the CSF1R kinase inhibitor BLZ945","volume":"6","author":"Beckmann","year":"2018","journal-title":"Acta Neuropathol. Commun."},{"issue":"10","key":"10.1016\/j.expneurol.2024.115095_bb0010","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1097\/j.pain.0000000000001291","article-title":"Trigeminal ganglion transcriptome analysis in 2 rat models of medication-overuse headache reveals coherent and widespread induction of pronociceptive gene expression patterns","volume":"159","author":"Buonvicino","year":"2018","journal-title":"Pain"},{"key":"10.1016\/j.expneurol.2024.115095_bb0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2019.113065","article-title":"Neuroimmunological characterization of a mouse model of primary progressive experimental autoimmune encephalomyelitis and effects of immunosuppressive or neuroprotective strategies on disease evolution","volume":"322","author":"Buonvicino","year":"2019","journal-title":"Exp. Neurol."},{"issue":"14","key":"10.1016\/j.expneurol.2024.115095_bb0020","doi-asserted-by":"crossref","first-page":"3342","DOI":"10.1111\/bph.15058","article-title":"Neuroprotection induced by dexpramipexole delays disease progression in a mouse model of progressive multiple sclerosis","volume":"177","author":"Buonvicino","year":"2020","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.expneurol.2024.115095_bb0025","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.neuroscience.2021.04.002","article-title":"Treatment with non-specific HDAC inhibitors administered after disease onset does not delay evolution in a mouse model of progressive multiple sclerosis","volume":"465","author":"Buonvicino","year":"2021","journal-title":"Neuroscience"},{"key":"10.1016\/j.expneurol.2024.115095_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2023.106015","article-title":"Early derangement of axonal mitochondria occurs in a mouse model of progressive but not relapsing-remitting multiple sclerosis","volume":"178","author":"Buonvicino","year":"2023","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.expneurol.2024.115095_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2023.106387","article-title":"The mitochondriogenic but not the immunosuppressant effects of mTOR inhibitors prompt neuroprotection and delay disease evolution in a mouse model of progressive multiple sclerosis","volume":"191","author":"Buonvicino","year":"2024","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.expneurol.2024.115095_bb0040","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/6816508","article-title":"beta3-Adrenoreceptors control mitochondrial dormancy in melanoma and embryonic stem cells","volume":"2018","author":"Calvani","year":"2018","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"7","key":"10.1016\/j.expneurol.2024.115095_bb0045","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1002\/1873-3468.13013","article-title":"Mitochondrial dysfunction and axon degeneration in progressive multiple sclerosis","volume":"592","author":"Campbell","year":"2018","journal-title":"FEBS Lett."},{"issue":"6376","key":"10.1016\/j.expneurol.2024.115095_bb0050","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1126\/science.aan4183","article-title":"Defective cholesterol clearance limits remyelination in the aged central nervous system","volume":"359","author":"Cantuti-Castelvetri","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.expneurol.2024.115095_bb0055","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.bbi.2015.06.019","article-title":"Dysregulation of sphingosine 1 phosphate receptor-1 (S1P1) signaling and regulatory lymphocyte-dependent immunosuppression in a model of post-fingolimod MS rebound","volume":"50","author":"Cavone","year":"2015","journal-title":"Brain Behav. Immun."},{"issue":"2","key":"10.1016\/j.expneurol.2024.115095_bb0060","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/S0165-5728(99)00089-2","article-title":"A screen of candidates from peaks of linkage: evidence for the involvement of myeloperoxidase in multiple sclerosis","volume":"98","author":"Chataway","year":"1999","journal-title":"J. Neuroimmunol."},{"issue":"Pt 4","key":"10.1016\/j.expneurol.2024.115095_bb0065","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1093\/brain\/awn004","article-title":"Myeloperoxidase-targeted imaging of active inflammatory lesions in murine experimental autoimmune encephalomyelitis","volume":"131","author":"Chen","year":"2008","journal-title":"Brain"},{"issue":"6540","key":"10.1016\/j.expneurol.2024.115095_bb0070","doi-asserted-by":"crossref","DOI":"10.1126\/science.abf1230","article-title":"Barcoded viral tracing of single-cell interactions in central nervous system inflammation","volume":"372","author":"Clark","year":"2021","journal-title":"Science"},{"issue":"8","key":"10.1016\/j.expneurol.2024.115095_bb0075","doi-asserted-by":"crossref","first-page":"E1896","DOI":"10.1073\/pnas.1800165115","article-title":"Normal aging induces A1-like astrocyte reactivity","volume":"115","author":"Clarke","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"10","key":"10.1016\/j.expneurol.2024.115095_bb0080","article-title":"A personalized approach in progressive multiple sclerosis: the current status of disease modifying therapies (DMTs) and future perspectives","volume":"17","author":"D'Amico","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.expneurol.2024.115095_bb0085","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.neuropharm.2017.01.039","article-title":"Post onset, oral rapamycin treatment delays development of mitochondrial encephalopathy only at supramaximal doses","volume":"117","author":"Felici","year":"2017","journal-title":"Neuropharmacology"},{"issue":"2","key":"10.1016\/j.expneurol.2024.115095_bb0090","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1148\/radiol.12111593","article-title":"Demyelinating diseases: myeloperoxidase as an imaging biomarker and therapeutic target","volume":"263","author":"Forghani","year":"2012","journal-title":"Radiology"},{"issue":"3","key":"10.1016\/j.expneurol.2024.115095_bb0095","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s00441-017-2626-8","article-title":"Myeloperoxidase-immunoreactive cells are significantly increased in brain areas affected by neurodegeneration in Parkinson's and Alzheimer's disease","volume":"369","author":"Gellhaar","year":"2017","journal-title":"Cell Tissue Res."},{"issue":"3","key":"10.1016\/j.expneurol.2024.115095_bb0100","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1111\/j.1471-4159.2004.02527.x","article-title":"Neuronal expression of myeloperoxidase is increased in Alzheimer\u2019s disease","volume":"90","author":"Green","year":"2004","journal-title":"J. Neurochem."},{"key":"10.1016\/j.expneurol.2024.115095_bb0105","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2022.815347","article-title":"Microglia polarization from M1 to M2 in neurodegenerative diseases","volume":"14","author":"Guo","year":"2022","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.expneurol.2024.115095_bb0110","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/725370","article-title":"Inflammation, Iron, energy failure, and oxidative stress in the pathogenesis of multiple sclerosis","volume":"2015","author":"Haider","year":"2015","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"6","key":"10.1016\/j.expneurol.2024.115095_bb0115","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.nucmedbio.2015.02.001","article-title":"Development of rapid multistep carbon-11 radiosynthesis of the myeloperoxidase inhibitor AZD3241 to assess brain exposure by PET microdosing","volume":"42","author":"Johnstr\u00f6m","year":"2020","journal-title":"Nucl. Med. Biol."},{"issue":"Pt 9","key":"10.1016\/j.expneurol.2024.115095_bb0120","doi-asserted-by":"crossref","first-page":"2687","DOI":"10.1093\/brain\/awv184","article-title":"Effect of the myeloperoxidase inhibitor AZD3241 on microglia: a PET study in Parkinson\u2019s disease","volume":"138","author":"Jucaite","year":"2015","journal-title":"Brain"},{"issue":"3","key":"10.1016\/j.expneurol.2024.115095_bb0125","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s12640-015-9547-7","article-title":"Failure of neuroprotection despite microglial suppression by delayed-start myeloperoxidase inhibition in a model of advanced multiple system atrophy: clinical implications","volume":"28","author":"Kaindlstorfer","year":"2015","journal-title":"Neurotox. Res."},{"issue":"4","key":"10.1016\/j.expneurol.2024.115095_bb0130","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1084\/jem.20141656","article-title":"Inefficient clearance of myelin debris by microglia impairs remyelinating processes","volume":"212","author":"Lampron","year":"2015","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.expneurol.2024.115095_bb0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2022.105895","article-title":"Cannabidiol inhibits microglia activation and mitigates neuronal damage induced by kainate in an in-vitro seizure model","volume":"174","author":"Landucci","year":"2022","journal-title":"Neurobiol. Dis."},{"issue":"11","key":"10.1016\/j.expneurol.2024.115095_bb0140","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1002\/glia.22597","article-title":"Mechanisms of white matter damage in multiple sclerosis","volume":"62","author":"Lassmann","year":"2014","journal-title":"Glia"},{"issue":"3","key":"10.1016\/j.expneurol.2024.115095_bb0145","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.bbadis.2015.09.018","article-title":"Oxidative stress and its impact on neurons and glia in multiple sclerosis lesions","volume":"1862","author":"Lassmann","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"issue":"2","key":"10.1016\/j.expneurol.2024.115095_bb0150","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s00401-020-02179-x","article-title":"Enhanced axonal response of mitochondria to demyelination offers neuroprotection: implications for multiple sclerosis","volume":"140","author":"Licht-Mayer","year":"2020","journal-title":"Acta Neuropathol."},{"issue":"7638","key":"10.1016\/j.expneurol.2024.115095_bb0155","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/nature21029","article-title":"Neurotoxic reactive astrocytes are induced by activated microglia","volume":"541","author":"Liddelow","year":"2017","journal-title":"Nature"},{"issue":"20","key":"10.1016\/j.expneurol.2024.115095_bb0160","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232012250","article-title":"Non-canonical functions of myeloperoxidase in immune regulation, tissue inflammation and Cancer","volume":"23","author":"Lockhart","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.expneurol.2024.115095_bb0165","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1111\/j.1365-2990.2008.00987.x","article-title":"Review: mitochondria and disease progression in multiple sclerosis","volume":"34","author":"Mahad","year":"2008","journal-title":"Neuropathol. Appl. Neurobiol."},{"issue":"6","key":"10.1016\/j.expneurol.2024.115095_bb0170","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1002\/glia.23980","article-title":"Activated microglia drive demyelination via CSF1R signaling","volume":"69","author":"Marzan","year":"2021","journal-title":"Glia"},{"issue":"3","key":"10.1016\/j.expneurol.2024.115095_bb0175","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.pneurobio.2010.06.005","article-title":"Animal models of multiple sclerosis--potentials and limitations","volume":"92","author":"Mix","year":"2010","journal-title":"Prog. Neurobiol."},{"issue":"1\u20132","key":"10.1016\/j.expneurol.2024.115095_bb0180","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0165-5728(97)00089-1","article-title":"Immunohistochemical and genetic evidence of myeloperoxidase involvement in multiple sclerosis","volume":"78","author":"Nagra","year":"1997","journal-title":"J. Neuroimmunol."},{"issue":"4","key":"10.1016\/j.expneurol.2024.115095_bb0185","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/nm.2324","article-title":"A reversible form of axon damage in experimental autoimmune encephalomyelitis and multiple sclerosis","volume":"17","author":"Nikic","year":"2011","journal-title":"Nat. Med."},{"key":"10.1016\/j.expneurol.2024.115095_bb0190","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.expneurol.2018.05.021","article-title":"Csf1R inhibition attenuates experimental autoimmune encephalomyelitis and promotes recovery","volume":"307","author":"Nissen","year":"2018","journal-title":"Exp. Neurol."},{"issue":"4","key":"10.1016\/j.expneurol.2024.115095_bb0195","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23042245","article-title":"Promising treatment for multiple sclerosis: mitochondrial transplantation","volume":"23","author":"Picone","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.expneurol.2024.115095_bb0200","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.clim.2016.06.017","article-title":"The contribution of neutrophils to CNS autoimmunity","volume":"189","author":"Pierson","year":"2018","journal-title":"Clin. Immunol."},{"issue":"2","key":"10.1016\/j.expneurol.2024.115095_bb0205","doi-asserted-by":"crossref","first-page":"824","DOI":"10.4049\/jimmunol.0902606","article-title":"Hypochlorous acid: a natural adjuvant that facilitates antigen processing, cross-priming, and the induction of adaptive immunity","volume":"184","author":"Prokopowicz","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.expneurol.2024.115095_bb0210","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.61798","article-title":"Enhancing mitochondrial activity in neurons protects against neurodegeneration in a mouse model of multiple sclerosis","volume":"10","author":"Rosenkranz","year":"2021","journal-title":"Elife"},{"issue":"8","key":"10.1016\/j.expneurol.2024.115095_bb0215","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1073\/pnas.1615413114","article-title":"Sphingosine 1-phosphate receptor modulation suppresses pathogenic astrocyte activation and chronic progressive CNS inflammation","volume":"114","author":"Rothhammer","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"4","key":"10.1016\/j.expneurol.2024.115095_bb0220","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1007\/s00401-013-1082-0","article-title":"Microglial nodules in early multiple sclerosis white matter are associated with degenerating axons","volume":"125","author":"Singh","year":"2013","journal-title":"Acta Neuropathol."},{"issue":"8","key":"10.1016\/j.expneurol.2024.115095_bb0225","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1080\/13543776.2020.1780210","article-title":"A patent review of myeloperoxidase inhibitors for treating chronic inflammatory syndromes (focus on cardiovascular diseases, 2013-2019)","volume":"30","author":"Soubhye","year":"2020","journal-title":"Expert Opin. Ther. Pat."},{"issue":"4","key":"10.1016\/j.expneurol.2024.115095_bb0230","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s12640-011-9294-3","article-title":"Myeloperoxidase inhibition ameliorates multiple system atrophy-like degeneration in a transgenic mouse model","volume":"21","author":"Stefanova","year":"2012","journal-title":"Neurotox. Res."},{"issue":"4","key":"10.1016\/j.expneurol.2024.115095_bb0235","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1002\/ana.26585","article-title":"Ultrastructural axon-myelin unit alterations in multiple sclerosis correlate with inflammation","volume":"93","author":"van den Bosch","year":"2023","journal-title":"Ann. Neurol."},{"issue":"3","key":"10.1016\/j.expneurol.2024.115095_bb0240","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.molmed.2013.11.007","article-title":"Mitochondrial dysfunction contributes to neurodegeneration in multiple sclerosis","volume":"20","author":"Witte","year":"2014","journal-title":"Trends Mol. Med."},{"issue":"3","key":"10.1016\/j.expneurol.2024.115095_bb0245","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1097\/WNR.0000000000000948","article-title":"Inhibition of myeloperoxidase by N-acetyl lysyltyrosylcysteine amide reduces experimental autoimmune encephalomyelitis-induced injury and promotes oligodendrocyte regeneration and neurogenesis in a murine model of progressive multiple sclerosis","volume":"29","author":"Yu","year":"2018","journal-title":"Neuroreport"},{"issue":"4","key":"10.1016\/j.expneurol.2024.115095_bb0250","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1111\/jnc.13426","article-title":"Inhibition of myeloperoxidase at the peak of experimental autoimmune encephalomyelitis restores blood-brain barrier integrity and ameliorates disease severity","volume":"136","author":"Zhang","year":"2016","journal-title":"J. Neurochem."},{"issue":"7","key":"10.1016\/j.expneurol.2024.115095_bb0255","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1093\/brain\/awx113","article-title":"Loss of \u2018homeostatic\u2019 microglia and patterns of their activation in active multiple sclerosis","volume":"140","author":"Zrzavy","year":"2017","journal-title":"Brain"}],"container-title":["Experimental Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488624004217?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488624004217?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T05:58:35Z","timestamp":1738216715000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014488624004217"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":51,"alternative-id":["S0014488624004217"],"URL":"https:\/\/doi.org\/10.1016\/j.expneurol.2024.115095","relation":{},"ISSN":["0014-4886"],"issn-type":[{"value":"0014-4886","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Microglial suppression by myeloperoxidase inhibitor does not delay neurodegeneration in a mouse model of progressive multiple sclerosis","name":"articletitle","label":"Article Title"},{"value":"Experimental Neurology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.expneurol.2024.115095","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"115095"}}